ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Renaissance BioScience Secures An Australian Patent for Novel RNA Production and Delivery Technology





Proprietary yeast-based technology platform for producing and delivering RNA with applications in multiple large-scale global industries

VANCOUVER, BC, September 04, 2025 /24-7PressRelease/ -- Renaissance BioScience Corp. is pleased to announce that it has been granted another patent for its innovative yeast-based platform technology for the low-cost production and effective delivery of RNA. The new patent, awarded by the Australian patent office, is the second patent awarded for this RNA technology IP, with more jurisdictions pending. The first patent was awarded by China. This Australian patent joins the company's extensive IP portfolio of issued and pending patents for multiple end-use markets.

Renaissance's most commercially advanced application of its yeast-based RNA production and delivery system is a suite of RNAi-based biopesticide products designed for a precise, targeted approach to pest control. These RNAi-based biopesticides have an improved environmental safety profile compared to broad spectrum chemical pesticides but with similar cost structures when produced at scale. Importantly, this technology works seamlessly with existing farming practices and equipment.

As Australia is one of the world's most innovative and largest agricultural economies, the timing of this patent issuance corresponds well with Renaissance's current commercial agriculture application of this powerful technology.

In addition to use as a safe, effective and inexpensive insecticide for agriculture and other insect biocontrol uses, this RNA technology platform holds excellent potential in additional multi-billion-dollar market applications, particularly for animal health and human medicines.

Yeast-based platform technology addresses key challenges of RNA for broad industry uses

RNA is a powerful tool but has been restricted from use in many industrial applications due to a high cost of production and extreme fragility of the RNA molecules. The Renaissance RNA technology platform solves these problems and allows for significantly expanded use of RNA across multiple industries.

About Renaissance BioScience Corp.
Based in Vancouver, Canada, Renaissance is a global leading yeast bioengineering company developing innovative, market-ready, functional microorganisms that provide cost-effective solutions to address a broad range of environmental, health and industrial challenges in agriculture, animal and human health, food and beverage, and energy. More information: www.renaissancebioscience.com.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.